Hostname: page-component-77c89778f8-n9wrp Total loading time: 0 Render date: 2024-07-21T04:19:44.987Z Has data issue: false hasContentIssue false
  • English
  • Français

Bio-Inspired Morphogens and Biomimetic Biomaterials for Regenerative Medicine

Published online by Cambridge University Press:  15 February 2011

A. Hari Reddi
A. Hari Reddi*
Affiliation:
Center for Tissue Regeneration and Repair Department of Orthopaedic SurgeryUniversity of California, Davis School of Medicine Sacramento, California 95817, USA
Get access

Abstract

Regenerative medicine is the science of design and manufacture of parts for functional restoration of damaged tissues due to cancer, disease and trauma. Morphogenesis is the developmental cascade of pattern formation, body plan establishment and differentiation of tissues culminating in adult form. Regeneration in general, recapitulates in parts, embryonic morphogenesis. Thus, the principles of morphogenesis can be applied to tissue engineering for regenerative medicine and surgery. The threekey ingredients for tissue engineering and regenerative medicine are inductive morphogens, responding stem cells, and extracellular matrix materials. Therefore bioactive morphogens can be integrated into materials for functional restoration by tissue engineering. A morphogen is a morphogenetic protein signal that acts on responding stem cells. Bone morphogenesis is induced by bone morphogenetic proteins (BMPs). BMPs play a role in pattern formation, cell differentiation, maintenance and regeneration of tissues. BMPs are pleiotropic and act on chemotaxis, mitosis and differentiation of progenitor stem cells. There are nearly twenty BMPs in the human genome. BMPs have actions beyond bone in development of teeth, heart, kidney, eye, skin, and brain. Thus, BMPs may be called body morphogenetic proteins. Stem cells are primordial cells with unlimited replicative potential and can be programmed by morphogens such as BMPs. Extracellular matrix is the native scaffolding material that can be used to deliver morphogens such as BMPs for tissue engineering of bone. Biomimetic materials are typically synthetic, polymeric structures that mimic extracellular matrix scaffolding by presenting the cellular binding sites found within collagens, fibronectin, proteoglycans and glycoproteins. Materials that mimic extracellular matrix scaffolding such as BMPs bind to collagens I&IV, heparan sulfate and heparin. BMPs bound to collagen acts as a composite biomaterial to initiate bone formation and the shape can be molded by an appropriate template. In addition to including BMPs in a carrier matrix, the geometry of the carrier matrix is critical for optimal tissue engineering. For example: collagen particles smaller than 44μm are feeble in bone induction compared to the coarse (420μm) particles. Gene therapy approaches using genes for morphogenesis such as BMPs allows a sustained, prolonged secretion of gene products. Thus, morphogens integrated into biomaterials may be useful in regenerative medicine.

Type
Research Article
Information
MRS Online Proceedings Library (OPL) , Volume 774: Symposium O – Materials Inspired by Biology , 2003 , O1.1
Copyright
Copyright © Materials Research Society 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Reddi, A. H. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol 16, 247–52. (1998).Google Scholar
2. Senn, N. On the healing of aseptic bone cavities by implantation of antiseptic decalcified bone. Am. J. Med. Sci. 98, 219–240 (1889).Google Scholar
3. Lacroix, P. Recent investigations on the growth of bone. Nature 156, 576 (1945).Google Scholar
4. Urist, M. R. Bone: formation by autoinduction. Science 150, 893–9. (1965).Google Scholar
5. Reddi, A. H. & Huggins, C. Biochemical sequences in the transformation of normal fibroblasts in adolescent rats. Proc Natl Acad Sci U S A 69, 1601–5 (1972).Google Scholar
6. Reddi, A. H. Cell biology and biochemistry of endochondral bone development. Coll Relat Res 1, 209–26. (1981).Google Scholar
7. Reddi, A. H. & Anderson, W. A. Collagenous bone matrix-induced endochondral ossification hemopoiesis. J Cell Biol 69, 557–72. (1976).Google Scholar
8. Weiss, R. E. & Reddi, A. H. Synthesis and localization of fibronectin during collagenous matrixmesenchymal cell interaction and differentiation of cartilage and bone in vivo. Proc Natl Acad Sci U S A 77, 2074–8 (1980).Google Scholar
9. Reddi, A. H. Bone and cartilage differentiation. Curr Opin Genet Dev 4, 737–44. (1994).Google Scholar
10. Sampath, T. K. & Reddi, A. H. Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proc Natl Acad Sci U S A 78, 7599–603. (1981).Google Scholar
11. Sampath, T. K. & Reddi, A. H. Homology of bone-inductive proteins from human, monkey, bovine, and rat extracellular matrix. Proc Natl Acad Sci U S A 80, 6591–5 (1983).Google Scholar
12. Luyten, F. P. et al. Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation. J Biol Chem 264, 13377–80. (1989).Google Scholar
13. Wozney, J. M. et al. Novel regulators of bone formation: molecular clones and activities. Science 242, 1528–34. (1988).Google Scholar
14. Griffith, D. L., Keck, P. C., Sampath, T. K., Rueger, D. C. & Carlson, W. D. Three-Dimensional Structure of Recombinant Human Osteogenic Protein 1 - Structural Paradigm for the Transforming Growth Factor Beta Superfamily. Proceedings of the National Academy of Sciences of the United States of America 93, 878–883 (1996).Google Scholar
15. Chang, S. C. et al. Cartilage-derived morphogenetic proteins. New members of the transforming growth factor-beta superfamily predominantly expressed in long bones during human embryonic development. J Biol Chem 269, 28227–34. (1994).Google Scholar
16. Storm, E. E. et al. Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily. Nature 368, 639–43. (1994).Google Scholar
17. Cunningham, N. S., Paralkar, V. & Reddi, A. H. Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression. Proc Natl Acad Sci U S A 89, 11740–4. (1992).Google Scholar
18. Heldin, C. H., Miyazono, K. & Dijke, ten, P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465–71. (1997).Google Scholar
19. Zimmerman, L. B., De Jesus-Escobar, J. M. & Harland, R. M. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86, 599–606. (1996).Google Scholar
20. Hsu, D. R., Economides, A. N., Wang, X., Eimon, P. M. & Harland, R. M. The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities. Mol Cell 1, 673–83 (1998).Google Scholar
21. Bostrom, M. et al. Use of Bone Morphogenetic Protein-2 in the Rabbit Ulnar Nonunion Model. Clinical Orthopaedics and Related Research, 272–282 (1996).Google Scholar
22. Boyne, P. J. et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent 17, 11–25 (1997).Google Scholar
23. Cochran, D. L., Schenk, R., Buser, D., Wozney, J. M. & Jones, A. A. Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants. J Periodontol 70, 139–50. (1999).Google Scholar
24. Cook, S. D. et al. The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J Bone Joint Surg Am 76, 827–38 (1994).Google Scholar
25. Cook, S. D., Dalton, J. E., Tan, E. H., Whitecloud, T. S., 3rd & Rueger, D. C. In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions. Spine 19, 1655–63 (1994).Google Scholar
26. Hollinger, J. et al. Poly(Alpha-Hydroxy Acid) Carrier for Delivering Recombinant Human Bone Morphogenetic Protein-2 for Bone Regeneration. Journal of Controlled Release 39, 287–304 (1996).Google Scholar
27. Yamaguchi, A. et al. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 113, 681–7 (1991).Google Scholar
28. Ripamonti, U. Osteoinduction in porous hydroxyapatite implanted in heterotopic sites of different animal models. Biomaterials 17, 31–5 (1996).Google Scholar
29. Ripamonti, U., Ma, S. & Reddi, A. H. The critical role of geometry of porous hydroxyapatite delivery system in induction of bone by osteogenin, a bone morphogenetic protein. Matrix 12, 202–12. (1992).Google Scholar
30. Ripamonti, U. et al. Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1, bone morphogenetic protein-7). Growth Factors 13, 273–89 (1996).Google Scholar
31. Khouri, R. K., Koudsi, B. & Reddi, H. Tissue transformation into bone in vivo. A potential practical application. Jama 266, 1953–5 (1991).Google Scholar